Childhood asthma biomarkers including zinc: An exploratory cross-sectional study

Hoda Atef Abdelsattar Ibrahim1,2, Mona Mohsen3, Boles Salep Aziz Hanna3

  • 1Pediatric Clinical Nutrition Unit, Faculty of Medicine, Cairo University, Cairo 12613, Egypt.

Insights

Serum zinc levels did not significantly differ between children with asthma and healthy children. However, serum ferritin and immunoglobulin E levels were higher in asthmatic children, suggesting ferritin may indicate asthma control.

Area of Science:

  • Pediatric Allergy and Immunology
  • Nutritional Biochemistry
  • Respiratory Medicine

Background:

  • Childhood bronchial asthma (BA) is a chronic inflammatory respiratory disease.
  • Nutritional status, particularly zinc levels, may influence allergic conditions like asthma.
  • Investigating biomarkers for asthma management is crucial.

Purpose of the Study:

  • To compare serum zinc levels in children diagnosed with bronchial asthma versus healthy controls.
  • To assess serum ferritin, iron, hemoglobin (Hb), and immunoglobulin E (IgE) levels in asthmatic children.
  • To explore potential correlations between these markers and asthma severity.

Main Methods:

  • A cross-sectional study involving 40 children with BA and 21 healthy children.
  • Serum zinc, ferritin, iron, Hb, and IgE levels were measured.
  • Statistical analyses included independent t-tests, Mann-Whitney tests, Kruskal-Wallis, and Spearman's rank correlation.

Main Results:

  • No significant difference in serum zinc levels was found between asthmatic and healthy children (P=0.115).
  • Asthmatic children exhibited significantly higher serum ferritin (P=0.006) and IgE (P=0.001) levels.
  • Asthma severity did not correlate significantly with serum ferritin or IgE levels.

Conclusions:

  • Serum zinc levels do not appear to be a distinguishing factor between asthmatic and healthy children.
  • Elevated serum ferritin may serve as a potential indicator for asthma control in children.
  • Serum IgE levels were not found to be reliable markers for asthma severity in this cohort.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
391
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
284
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K